Literature DB >> 15060775

[Osteosarcoma of the pelvisTwo case reports and review of the literature].

S Bading1, E Mössinger, H Rosenthal, F Länger, L Bastian.   

Abstract

Primary malignant neoplasms of the bone are rare. One of the most common bone tumors is osteosarcoma, most often localized in the metaphysis of adolescent long bones. The sacrum is concerned in only about 1%. Primary bone sarcomas of the pelvis are usually recognized after they have grown to a considerable size. Osteosarcoma patients from Germany, Austria, and Switzerland are treated by neoadjuvant chemotherapy combined with complete surgical excision according to the Cooperative Osteosarcoma Study Group (COSS). Based on a review of the literature, diagnosis, treatment, and complications of two cases of sacrum osteosarcoma are introduced.

Entities:  

Mesh:

Year:  2004        PMID: 15060775     DOI: 10.1007/s00113-004-0753-7

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  17 in total

1.  Osteosarcoma of the pelvis. Oncologic results of 40 patients.

Authors:  A Kawai; A G Huvos; P A Meyers; J H Healey
Journal:  Clin Orthop Relat Res       Date:  1998-03       Impact factor: 4.176

2.  Targeted radiotherapy of osteosarcoma using 153 Sm-EDTMP. A new promising approach.

Authors:  O S Bruland; A Skretting; O P Solheim; M Aas
Journal:  Acta Oncol       Date:  1996       Impact factor: 4.089

3.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

4.  High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.

Authors:  C Franzius; S Bielack; J Sciuk; B Vollet; H Jürgens; O Schober
Journal:  Nuklearmedizin       Date:  1999       Impact factor: 1.379

5.  Osteogenic sarcoma. A study of six hundred cases.

Authors:  D C Dahlin; M B Coventry
Journal:  J Bone Joint Surg Am       Date:  1967-01       Impact factor: 5.284

Review 6.  Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.

Authors:  K Winkler; P Bieling; S Bielack; G Delling; C Dose; H Jürgens; R Kotz; J Ritter; M Salzer-Kuntschik
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

7.  High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.

Authors:  Peter M Anderson; Gregory A Wiseman; Angela Dispenzieri; Carola A S Arndt; Lynn C Hartmann; William A Smithson; Brian P Mullan; Oyvind S Bruland
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

8.  New indications for computer-assisted surgery: tumor resection in the pelvis.

Authors:  Tobias Hüfner; Maurício Kfuri; Michael Galanski; Leonard Bastian; Martin Loss; Tim Pohlemann; Christian Krettek
Journal:  Clin Orthop Relat Res       Date:  2004-09       Impact factor: 4.176

Review 9.  [Options for surgical treatment of malignant bone tumors].

Authors:  C Gebert; J Hardes; C Hoffmann; W Winkelmann; G Gosheger
Journal:  Chirurg       Date:  2002-12       Impact factor: 0.955

10.  Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.

Authors:  K Winkler; G Beron; R Kotz; M Salzer-Kuntschik; J Beck; W Beck; W Brandeis; W Ebell; R Erttmann; U Göbel
Journal:  J Clin Oncol       Date:  1984-06       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.